British Columbia Investment Management Corp Pfizer Inc Transaction History

British Columbia Investment Management Corp

$14.3 Billion
Q1 2024

A detailed history of British Columbia Investment Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 676,411 shares of PFE stock, worth $18.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

676,411

Previous 649,936 4.07%

Holding current value

$18.9 Million

Previous $18.7 Million 0.32%

% of portfolio

0.13%

Previous 0.15%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $685,437 - $787,101	26,475 Added 4.07%	676,411 $18.8 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $3.57 Million - $4.64 Million	136,587 Added 26.61%	649,936 $18.7 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $107,212 - $125,320	3,341 Added 0.66%	513,349 $17 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $291,524 - $337,287	8,071 Added 1.61%	510,008 $18.7 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $152,951 - $199,120	3,883 Added 0.78%	501,937 $20.5 Million

Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $2.42 Million - $3.16 Million	-57,954 Reduced 10.42%	498,054 $25.5 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $4.26 Million - $5.19 Million	-97,238 Reduced 14.89%	556,008 $24.3 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $9.99 Million - $11.8 Million	-214,641 Reduced 24.73%	653,246 $34.3 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $5.4 Million - $6.7 Million	-118,138 Reduced 11.98%	867,887 $44.9 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $2.03 Million - $3.02 Million	-49,243 Reduced 4.76%	986,025 $58.2 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $98,242 - $126,201	2,503 Added 0.24%	1,035,268 $44.5 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $4.31 Million - $4.88 Million	120,064 Added 13.15%	1,032,765 $40.4 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $932,026 - $1.05 Million	-27,830 Reduced 2.96%	912,701 $33.1 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $814,392 - $1.04 Million	-24,332 Reduced 2.52%	940,531 $34.6 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $2.46 Million - $2.88 Million	77,443 Added 8.73%	964,863 $35.4 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $8.5 Million - $10.3 Million	282,074 Added 46.6%	887,420 $29 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $18.9 Million - $27 Million	-699,841 Reduced 53.62%	605,346 $19.8 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $8.88 Million - $10.1 Million	269,671 Added 26.04%	1,305,187 $51.1 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $11.7 Million - $15.2 Million	-360,551 Reduced 25.83%	1,035,516 $37.2 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $484,327 - $543,787	13,097 Added 0.95%	1,396,067 $60.5 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $21.8 Million - $24 Million	-582,202 Reduced 29.63%	1,382,970 $58.7 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $6.72 Million - $7.66 Million	174,697 Added 9.76%	1,965,172 $85.8 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $17.8 Million - $21.7 Million	-517,820 Reduced 22.43%	1,790,475 $78.9 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $16.8 Million - $17.9 Million	-508,400 Reduced 18.05%	2,308,295 $83.7 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $8.47 Million - $9.83 Million	-265,463 Reduced 8.61%	2,816,695 $100 Million
Q4 2017 Feb 20, 2018	BUY	$33.26 - $35.29 $13.4 Million - $14.2 Million	402,638 Added 15.03%	3,082,158 $112 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $83.1 Million - $91.5 Million	2,679,520	2,679,520 $95.7 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Pfizer Inc Transaction History